An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition Medicines for Europe 27 Oct 2022 Health & Consumers
Energy Council (TTE) – Medicines for Europe Open letter to European Energy Ministers and responsible European Commissioners on inflation and energy costs impacting the supply of essential generic medicines Medicines for Europe 28 Sep 2022 Health & Consumers
EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability Medicines for Europe 20 Sep 2022 Health & Consumers
Medicines for Europe warns strongly against energy rationing for medicines production Medicines for Europe 20 Jul 2022 Health & Consumers
Smart reform of EU pharma and IP legislation key to boosting access to essential medicines Medicines for Europe 30 Jun 2022 Health & Consumers
The off-patent medicines industry is a vital part of the solution for healthcare resilience Medicines for Europe 30 Jun 2022 Health & Consumers
EU can do more for patients with smart use of biosimilar medicines Medicines for Europe 29 Apr 2022 Health & Consumers
Central & Eastern European patients have inequitable access to medicines for life-threatening conditions Medicines for Europe 25 Apr 2022 Health & Consumers
Repurposing: a golden opportunity for patient centric health investment in Europe Medicines for Europe 06 Apr 2022 Health & Consumers
Electronic product information: new report shows it is time to move from principles to action Medicines for Europe 25 Feb 2022 Health & Consumers
The European Commission needs to prioritise equitable access to biosimilar medicines in Europe Medicines for Europe 25 Jan 2022 Health & Consumers
Stronger mandate for European Medicines Agency should prioritise patient access to medicines Medicines for Europe 24 Jan 2022 Health & Consumers
Regulatory reforms critical to improve patient access to medicines Medicines for Europe 24 Jan 2022 Health & Consumers
Biosimilar medicines have delivered 18BN€ total savings for Europe but more action needed to translate this potential into patient access and sustainable health systems Medicines for Europe 16 Dec 2021 Health & Consumers
Commission study highlights market framework conditions are main driver for medicines shortages Medicines for Europe 10 Dec 2021 Health & Consumers
Access to essential medicines threatened by combination of increasing inflation and potential further price cuts in EU countries Medicines for Europe 26 Nov 2021 Health & Consumers
European Parliament report calls for increased use of off-patent medicines to improve patient access Medicines for Europe 25 Nov 2021 Health & Consumers
The EU must stop the offshoring of essential medicines manufacturing investments: ambitious, open and coherent policies must support competitive, robust and sustainable production of APIs and medicines Medicines for Europe 23 Nov 2021 Global Europe
Adjustments to IP framework needed to improve access to medicines in Europe Medicines for Europe 16 Nov 2021 Science & Policymaking
Access to medicines critical in European Parliament vote on EU IP action plan Medicines for Europe 12 Nov 2021 Health & Consumers
EU must learn from Covid-19 to improve crisis preparedness and response for the future Medicines for Europe 09 Nov 2021 Health & Consumers
European Commission pilot project on repurposing brings value added innovation to life Medicines for Europe 28 Oct 2021 Health & Consumers
Baton passes from Christoph Stoller to Rebecca Guntern as President of Medicines for Europe Medicines for Europe 01 Oct 2021 Health & Consumers
HERA must address outstanding weaknesses in EU pharma framework to be successful Medicines for Europe 16 Sep 2021 Health & Consumers
Orphan and paediatric reform should strive to improve access to medicine for rare disease patients and children Medicines for Europe 30 Jul 2021 Health & Consumers
EU must take the lead to ensure security of supply for medicines Medicines for Europe 16 Jun 2021 Health & Consumers
Open borders that prioritise essential goods key to medicines supply in Europe Medicines for Europe 02 Jun 2021 Health & Consumers
EU Industrial strategy should be key to improving medicines supply chains Medicines for Europe 17 May 2021 Health & Consumers
Off patent medicines essential for a fairer, healthier, and sustainable Europe says President Christoph Stoller Medicines for Europe 30 Apr 2021 Health & Consumers
European patients need improved access to biosimilar medicines Medicines for Europe 22 Apr 2021 Health & Consumers



The Federation of European Securities Exchanges (FESE)
Policy Intern
European Health Management Association
Director of Policy and Research
European and International Booksellers Federation
Communication & Events Intern
EPIA SolarPower Europe AISBL
Project Officer
Single Resolution Board
Vice-Chair and Director of SRB
Cecoforma , Loi 42 , Seauton
Event Project Manager
European Union Agency for the Cooperation of Energy Regulators
3 Head of Department Positions (AD11)